# Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial

Study · id `cardio:ct-nct04405258` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04405258](<https://clinicaltrials.gov/study/NCT04405258>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04405258

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 276 participants.

## Technical summary

Registry record NCT04405258. Randomized; single masking; primary purpose treatment. Start 2020-06-08 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 276 participants (enrolled count; ClinicalTrials.gov record NCT04405258, source copy `cardio:ctgov-nct04405258-2024-06-14`, retrieved 2026-10-26)
- Started: 2020-06-08 (actual) (ClinicalTrials.gov record NCT04405258, source copy `cardio:ctgov-nct04405258-2024-06-14`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT04405258, source copy `cardio:ctgov-nct04405258-2024-06-14`, retrieved 2026-10-26)
- Completion: 2026-06-30 (anticipated) (ClinicalTrials.gov record NCT04405258, source copy `cardio:ctgov-nct04405258-2024-06-14`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT04405258, source copy `cardio:ctgov-nct04405258-2024-06-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04405258-2024-06-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial
- Acronym: LEAP-AF
- Condition: Persistent Atrial Fibrillation
- Condition: Catheter Ablation
- Condition: Pulmonary Vein Isolation
- Condition: Posterior Wall Isolation
- Intervention (Procedure): Pulmonary vein isolation
- Intervention (Procedure): Left posterior wall isolation
- Lead sponsor: Institute for Clinical Effectiveness, Japan
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: b334017c4c9ebb4393a4b54d219efcadbdc363dcc9f4cb4385dfd79a92b1db9a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
